Adam Heller

Austin, TX, United States of America

Adam Heller

This inventor holds 276 USPTO granted patents and 106 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Analyte Monitoring Devices (CPC class A61B5-14532). Top assignees: Abbott Diabetes Care Inc., Therasense, Inc., E. Heller & Company. Active years: 1991-2024.

USPTO Granted Patents = 276 

% Patents Active = 44.6


 

Average Co-Inventor Count = 3.2

ph-index = 67

Forward Citations = 65,240(Granted Patents)

Forward Citations (Not Self Cited) = 59,002(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Alameda, CA (US) (2003)
  • Austin, TX (US) (1991 - 2024)

Company Filing History:


Years Active: 1991-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Analyte Monitoring
Hypoglycemic Detection
Pharmaceutical Suspensions
In Vivo Sensors
Electro-Osmotic Pumps
Redox Polymers
Graphene Rich Carbons
Small Volume Sensors
Ceria Nanoparticle Electrodes
Biological Fuel Cells
Lithium Ion Batteries
Chalcogen-Containing Anodes
276 patents (USPTO):Explore Patents

Title: Adam Heller: A Pioneer in Science and Technology

Introduction:

Throughout his illustrious career, Adam Heller has established himself as a groundbreaking innovator in the field of science and technology. With numerous awards and accolades to his name, Heller's contributions have had a significant impact on the industry. This article delves into his latest patents, highlights his remarkable career achievements, and explores his professional collaborations, shedding light on his immense contributions to the scientific community.

Latest Patents:

Adam Heller's remarkable expertise and ingenuity are exemplified by his impressive portfolio of 273 patents. Two notable recent inventions include:

1. Devices for the Administration of Pharmaceutical Suspensions:

Heller's invention features a drug delivery device anchored in the mouth that continuously administers a pharmaceutical suspension containing drug particles. This novel method holds great promise for improving the efficiency and effectiveness of drug delivery systems.

2. Analyte Monitoring Device and Methods of Use:

This groundbreaking invention encompasses an analyte monitor comprising a sensor, a sensor control unit, and a display unit. The technology utilizes an electrochemical sensor to obtain data, which is then transmitted via a receiver and displayed on the unit. This innovative approach has the potential to revolutionize analyte monitoring and greatly benefit patients.

Career Highlights:

Adam Heller's exemplary contributions to science and technology have garnered widespread recognition. Throughout his career, he has been honored with numerous awards and accolades, which serve as a testament to his immense talent and dedication. His revolutionary work has been extensively published in prestigious scientific journals, solidifying his position as a thought leader in the field.

Collaborations:

Heller has collaborated with esteemed professionals in the industry, including Ephraim Heller and Fredric C. Colman. These collaborations have resulted in significant advancements in the field, fostering a culture of innovation and expertise.

Conclusion:

Adam Heller's exceptional career in science and technology has been marked by groundbreaking innovations and remarkable achievements. With his impressive patent portfolio and invaluable contributions, Heller has left an indelible mark on the field. As a thought leader and innovator, his work continues to inspire and shape future breakthroughs in various aspects of science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…